Venrock Healthcare Capital Partners II, L.P. 13D/13G Filings for Surface Oncology, Inc. (SURF)

Venrock Healthcare Capital Partners II, L.P. 13D and 13G filings for Surface Oncology, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-02-16
4:10 pm
Sale
2020-12-3113GSurface Oncology, Inc.
SURF
Venrock Healthcare Capital Partners II, L.P.1,442,895
3.500%
-2,435,000decrease
(-62.79%)
Filing